| HOME >> BIOLOGY >> TECHNOLOGY |
0.94Diluted
$
0.46
$
0.28$
0.90
$
0.53Weighted average shares used in computation: Basic 25,875,16424,632,77425,738,14524,492,728Diluted 26,627,16026,738,27926,581,82426,802,683Other Comprehensive income, net of nil income taxes Foreign currency translation adjustment 136,1782,699,4261,313,1353,825,840Comprehensive income 19,728,84323,374,65438,623,96734,329,268Less: Comprehensive income attributable to the noncontrolling interest 6,750,9334,526,46511,766,7688,314,296Comprehensive income attributable to China Biologic Products, Inc.
$
12,977,910
$
18,848,189$
26,857,199
$
26,014,972CHINA BIOLOGIC PRODUCTS, INC. AND SUBSIDIARIES
UNAUDITED CONSOLIDATED BALANCE SHEETSJune 30, December 31, 20122011ASSETS Current Assets Cash
$
104,487,225$
89,411,835Short-term investment1,347,250-Accounts receivable, net of allowance for doubtful accounts 21,539,87916,757,368Inventories 69,744,36471,338,590Other receivables 1,843,1392,594,461Prepayments and prepaid expenses 2,063,4541,591,696Deferred tax assets 1,768,3191,999,563Total Current Assets 202,793,630183,693,513Property, plant and equipment, net 40,438,50440,546,539Intangible assets, net 5,109,9496,520,671Land use rights, net 5,779,9835,487,343Prepayments and deposits for property, plant and equipment 7,856,1304,287,492Equity method investment 9,888,2368,357,017Total Assets
$
271,866,432$
248,892,575LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities Short-term bank loans
$
-$
11,018,000Accounts payable 3,486,5674,996,463Due to related parties 4,597,7413,319,938Other payables and accrued expenses 23,364,02530,661,794Advance from customers 5,287,0224,365,523Advance from customers – a related party -486,602Income tax payable 3,227,5665,373,633Other taxes payable 2,280,8122,189,913Derivative liabilit
'/>"/>
| SOURCE China Biologic Products, Inc. Copyright©2012 PR Newswire. All rights reserved |